Enxiu Wang
Baise City, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Development of a rapid chimeric antigen receptor (CAR)-T production process and assessment of critical quality attributes
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: July 29, 2026
T-cell receptor-like chimeric antigen receptor T cells targeting mesothelin: A first-in-human dose-escalation trial for platinum-resistant advanced ovarian cancer.
Journal: Cancer
Published: August 07, 2025
Co-Expression of Dominant-Negative TGF-β Receptor 2 Enhances the Therapeutic Efficacy of Novel TREM1/DAP12-BB-Based CAR-T Cells in Solid Tumours.
Journal: Immunology
Published: July 24, 2024
Efficacy and safety of novel multiple-chain DAP-CAR-T cells targeting mesothelin in ovarian cancer and mesothelioma: a single-arm, open-label and first-in-human study.
Journal: Genome medicine
Published: February 06, 2024
A novel TREM1/DAP12-based multiple chain CAR-T cell targets PTK7 in ovarian cancer therapy.
Journal: Medical oncology (Northwood, London, England)
Published: May 07, 2023
Coexpression of c-Jun in multiple-chain DAP-CAR-engineered T-cells for solid tumor therapy.
Journal: Immunotherapy
Published: January 04, 2023
The Landscape of Cell and Gene Therapies for Solid Tumors.
Journal: Cancer cell
Published: January 12, 2021
TREM1/Dap12-based CAR-T cells show potent antitumor activity.
Journal: Immunotherapy
Published: July 04, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026